Annual Grant Award Dollars

Investigator Title Sponsor ID Dates Amount
Heidi Mills Andersen, MD NIEHS funded Training Program: Molecular Epidemiology in Children's Environmental Heath (MECEH) National Institutes of Health (University of Cincinnati) T32 ES010957 05/01/2015 - 04/30/2018 $55,296
David I Bernstein, MD Mouse and Guinea Pig Models for Cytomegalovirus and Herpes Simplex Viruses National Institutes of Health HHSN27200003 11/01/2017 - 10/31/2018 $736,623
David I Bernstein, MD Base IDIQ Contract Kick-Off National Institutes of Health HHSN272201700017I 10/19/2017 - 10/31/2017 $5,433
Steven Black, MD CISA Clinical Vaccine Safety Evaluation - Contributing Contractor Ctr for Disease Control and Prevention 200-2012-53661-0008 09/29/2017 - 09/28/2022 $39,143
Lara Danziger-Isakov, MD, MPH A Multicenter Prospective Study Human Adenovirus Infection and Disease in Pediatric Human Stem Cell Transplant Recipients National Institutes of Health (Children's Hospital of Philadelphia) 7300250621 07/01/2016 - 06/30/2021 $335,572
Lara Danziger-Isakov, MD, MPH A Phase II Multi-Center, Prospective, Randomized, Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant Recipients ? 6 Years of Age National Institutes of Health (Northwestern University Medical School) HHSN272201600016C 07/01/2016 - 06/30/2021 $249,363
Lara Danziger-Isakov, MD, MPH Comparison of High vs. Standard Dose Flu Vaccine in Pediatric Stem Cell Transplant Recipients National Institutes of Health (Vanderbilt University) U01 AI125135 08/19/2016 - 07/31/2019 $76,909
Lara Danziger-Isakov, MD, MPH CTOTC-08: B-cell Targeted Induction to Improve Outcomes in Pediatric Lung Transplantation National Institutes of Health (Washington University) U01 AI077810 03/01/2013 - 02/28/2019 $90,597
Lara Danziger-Isakov, MD, MPH CTOTC-11: Prevalence and Correlates of Post-Traumatic Stress Symptoms (PTSS) in Adolescent Solid Organ Transplant Recipients National Institutes of Health (Washington University) WU-18-129 03/01/2017 - 02/28/2018 $3,675
Lara Danziger-Isakov, MD, MPH CTOTC-11: Prevalence and Correlates of Post-Traumatic Stress Symptoms (PTSS) in Adolescent Solid Organ Transplant Recipients National Institutes of Health (Washington University) WU-18-129 03/01/2017 - 10/31/2018 $6,240
Lara Danziger-Isakov, MD, MPH CTOTC-14: A Retrospective Multicenter Study to Determine Clinical Outcomes in Subjects Previously Enrolled in the CTOTC-03 Study National Institutes of Health (Washington University) WU-18-231 03/01/2017 - 02/28/2019 $312
Lara Danziger-Isakov, MD, MPH CTOTC-08: B-cell Targeted Induction to Improve Outcomes in Pediatric Lung Transplantation National Institutes of Health (Washington University) WU-18-115 03/01/2017 - 02/28/2018 $10,797
Robert W Frenck, MD Vaccine and Treatment Evaluation Units (VTEUs) National Institutes of Health HHSN272201300016I 09/16/2013 - 09/15/2023 $13,995,763
Robert W Frenck, MD A Phase 1, Randomized, Controlled, Observer-blind Study to assess the Reactogenicity, Safety, and Immunogenicity of a Live Attenuated Universal Influenza Vaccine (cH8/1N1 LAIV) administered as a Single Priming Dose followed 3 months later by a Single Booster Dose of an Inactivated Universal Influenza Vaccine (cH5/1N1 IIV) (adjuvanted with AS03A or unadjuvanted) in 18 through 39 year-old Healthy Subjects, contrasted with a 2-dose Schedule of an Inactivated Universal Influenza Vaccine (cH8/1N1 IIV + AS03A followed 3 months later by cH5/1N1 IIV + AS03A). PATH Vaccine Solutions CVIA057 08/15/2017 - 12/31/2019 $1,059,869
Margaret K Hostetter, MD Pediatric Scientist Development Program (K12) 2017-2022" National Institutes of Health K12 HD000850 07/06/2017 - 06/30/2022 $1,425,957
Xi Jason Jiang, PhD Prevalence of P[6] and P[11] Rotaviruses in Developing Countries National Institutes of Health R21 AI130631 02/15/2017 - 01/31/2019 $213,360
Xi Jason Jiang, PhD A Novel Lactic Acid Bacteria-based Norovirus Vaccine National Institutes of Health (Ohio State University) R01 AI123661 03/10/2016 - 02/28/2021 $240,073
Xi Jason Jiang, PhD HBGA Receptors in Host Cell Entry and Infection of Norovirus National Institutes of Health (Purdue University) 4102-65270 12/01/2014 - 11/30/2019 $258,603
Xi Jason Jiang, PhD Universal Flu Vaccine by a Norovirus P Particle Platform US Department of Agriculture (Ohio State University) 2013-87015-20479 02/01/2013 - 01/31/2019 $191,917
Tony Jiang Antifungal Immunity controlled by Commensal Bacteria National Institutes of Health F30 DK107199 05/01/2015 - 04/30/2020 $38,012
Joseph Edward Qualls, PhD L-citrulline and Anti-tuberculosis Host Defense National Institutes of Health R01 AI116668 07/01/2016 - 06/30/2021 $390,000
Nancy M Sawtell, PhD Acute and Long-term Outcomes of Simulated Deep Space Radiation Exposure on Latent Viral CNS Infection and CNS Pathology. National Aeronautics and Space Admin (National Aeronautics and Space Admin) NNX13AO47G 01/01/2014 - 05/31/2018 $124,000
Elizabeth Schlaudecker, MD Clinical Study of the Safety of Simultaneous versus Sequential Administration of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) and Inactivated Influenza Vaccine (IIV) in Pregnant Women - Pilot Contributing Site Logical Follow-On Ctr for Disease Control and Prevention 200-2012-53661-0009 09/29/2017 - 12/28/2018 $146,341
Paul W Spearman, MD Viral and Cellular Determinants of HIV-1 Assembly National Institutes of Health R01 GM111027 12/15/2016 - 08/31/2018 $310,658
Paul W Spearman, MD Mucosal Protection Against HIV Generated by PIV5 Priming and VLP Boosting National Institutes of Health R01 AI111863 10/01/2016 - 03/31/2019 $614,891
Paul W Spearman, MD HIV-1 Particle Capture and VCC Formation in Microglia National Institutes of Health R21 NS107031 04/15/2018 - 03/31/2020 $238,500
Mary Allen Staat, MD Enhanced Surveillance for New Vaccine Preventable Diseases Ctr for Disease Control and Prevention U01IP001059 09/01/2016 - 08/31/2021 $2,200,000
Mary Allen Staat, MD Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines (Contributing) Ctr for Disease Control and Prevention 200-2012-53661 09/15/2017 - 09/14/2018 $57,927
Sing Sing Way, MD, PhD HHMI Faculty Scholar Award Howard Hughes Medical Institute 55108587 11/01/2016 - 10/31/2021 $120,000
Sing Sing Way, MD, PhD Maternal Regulatory T-cell Antigen-specificity National Institutes of Health R01 AI120202 11/05/2015 - 10/31/2020 $390,000
Sing Sing Way, MD, PhD Immunological Identity Redefined by Genetically Foreign Microchimeric Cells National Institutes of Health DP1 AI131080 09/01/2016 - 07/31/2021 $1,092,000
Sing Sing Way, MD, PhD Commensal Fungi Positively Calibrate Asthma Susceptibility National Institutes of Health R21 AI128932 12/01/2016 - 11/30/2018 $234,000
Sing Sing Way, MD, PhD Functional Immune Tolerance to Non-inherited Maternal Antigen National Institutes of Health R01 AI124657 02/09/2017 - 01/31/2022 $390,000
Total Annual Grant Award Dollars $25,341,831

Annual Industry Award Dollars

Investigator Industry Sponsor Amount
David I Bernstein, MD Genocea Biosciences, Inc. $152,492
Lara Danziger-Isakov, MD-MPH Astellas Pharma US, Inc. $249,696
Lara Danziger-Isakov, MD-MPH Merck & Company, Inc. $202,409
Lara Danziger-Isakov, MD-MPH Shire Human Genetic Therapies $46,232
Robert W Frenck, MD Janssen Research & Development, LLC $54,684
Mary Allen Staat, MD Cepheid $15,000
Total Annual Industry Award Dollars $720,513